Axsome Therapeutics Inc (AXSM)
74.80
+0.61
(+0.82%)
USD |
NASDAQ |
May 03, 16:00
75.50
+0.70
(+0.94%)
After-Hours: 20:00
Axsome Therapeutics Price: 74.80 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 75.57 | 76.32 | 74.36 | 74.80 | 766022.0 |
| May 02, 2024 | 75.01 | 75.01 | 73.52 | 74.19 | 397689.0 |
| May 01, 2024 | 74.03 | 76.39 | 73.28 | 74.89 | 456684.0 |
| Apr 30, 2024 | 73.30 | 74.98 | 73.02 | 73.76 | 436112.0 |
| Apr 29, 2024 | 74.97 | 75.68 | 73.52 | 73.69 | 505861.0 |
| Apr 26, 2024 | 70.97 | 72.43 | 69.70 | 71.71 | 272333.0 |
| Apr 25, 2024 | 70.39 | 72.47 | 69.53 | 71.52 | 412254.0 |
| Apr 24, 2024 | 72.61 | 73.14 | 69.92 | 71.17 | 583799.0 |
| Apr 23, 2024 | 71.53 | 74.34 | 70.30 | 73.08 | 703139.0 |
| Apr 22, 2024 | 68.14 | 71.30 | 67.16 | 71.10 | 498859.0 |
| Apr 19, 2024 | 65.50 | 68.14 | 65.50 | 67.90 | 930832.0 |
| Apr 18, 2024 | 69.44 | 70.08 | 65.61 | 65.72 | 834897.0 |
| Apr 17, 2024 | 69.17 | 70.78 | 68.16 | 69.71 | 399847.0 |
| Apr 16, 2024 | 67.41 | 70.06 | 67.10 | 68.81 | 467399.0 |
| Apr 15, 2024 | 68.73 | 69.30 | 66.93 | 68.21 | 430813.0 |
| Apr 12, 2024 | 71.75 | 72.28 | 68.28 | 69.15 | 594653.0 |
| Apr 11, 2024 | 71.11 | 71.95 | 68.70 | 71.73 | 782192.0 |
| Apr 10, 2024 | 70.71 | 71.60 | 70.00 | 70.97 | 571892.0 |
| Apr 09, 2024 | 72.00 | 73.47 | 71.80 | 72.64 | 382733.0 |
| Apr 08, 2024 | 72.06 | 72.74 | 71.62 | 72.11 | 588562.0 |
| Apr 05, 2024 | 71.69 | 73.49 | 71.12 | 72.25 | 391919.0 |
| Apr 04, 2024 | 73.98 | 74.98 | 71.58 | 72.17 | 409931.0 |
| Apr 03, 2024 | 74.45 | 74.45 | 72.02 | 73.50 | 623779.0 |
| Apr 02, 2024 | 75.91 | 76.18 | 74.03 | 74.56 | 645897.0 |
| Apr 01, 2024 | 79.80 | 80.00 | 76.05 | 76.99 | 586112.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
16.71
Minimum
Oct 01 2019
106.24
Maximum
Dec 26 2019
58.02
Average
63.80
Median
Aug 31 2022
Price Benchmarks
| Krystal Biotech Inc | 161.10 |
| Amgen Inc | 311.29 |
| Vertex Pharmaceuticals Inc | 401.08 |
| Alnylam Pharmaceuticals Inc | 152.33 |
| Catalyst Pharmaceuticals Inc | 14.72 |
Price Related Metrics
| PS Ratio | 12.55 |
| Price to Book Value | 18.56 |
| Earnings Yield | -6.95% |
| Market Cap | 3.544B |